Get started
Author

Marcello Riva

High rate of profound clonal and renal responses with daratumumab treatment in heavily pre‐treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
2020 · Paolo Milani, Francesca Fazio, et al. · American Journal of Hematology · 37
PDF
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
2017 · Andrea Visentin, Silvia Imbergamo, et al. · Oncotarget · 30
PDF
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
2021 · Giulia Bega, Jacopo Olivieri, et al. · Cancers · 16
PDF
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients
2019 · Marcello Riva, Federica Lessi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 16
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study
2025 · Mirko Farina, Simona Bernardi, et al. · Bone Marrow Transplantation · 14
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study
2020 · Andrea Visentin, Vincenzo Nasillo, et al. · HemaSphere · 14
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study
2025 · Carlo Visco, Valentina Tabanelli, et al. · The Lancet Haematology · 8
PDF
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital
2023 · Nicolò Danesin, Mariella Lo Schirico, et al. · HemaSphere · 7
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study
2025 · Ernesto Vigna, Enrica Antonia Martino, et al. · Hematological Oncology · 5
IDH2R172 mutation in angioimmunoblastic T‐cell lymphoma: A retrospective multicenter case series
2022 · Marcello Riva, Maria Chiara Tisi, et al. · European Journal Of Haematology · 5
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort
2026 · Enrica Antonia Martino, Annalisa Pitino, et al. · Blood Advances · 4
PDF
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case report
2024 · Francesca Elice, Roberta Sommaggio, et al. · Haematologica · 3
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib
2020 · Greta Scapinello, Marcello Riva, et al. · Annals of Hematology · 3
Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis
2019 · Paolo Milani, Francesca Fazio, et al. · Blood · 3
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study
2026 · Nicolò Danesin, Francesco Autore, et al. · British Journal of Haematology · 2
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B‐Cell Lymphoma in the Real‐Life Patient Journey
2026 · Lisa Argnani, Cinzia Pellegrini, et al. · Hematological Oncology · 2
461 | Outcomes of Car T‐cell Therapy in Transformed Indolent Non‐hodgkin Lymphomas and De Novo Dlbcl: a Comparative Analysis From the Italian Car T‐sie Study
2025 · Nicole Fabbri, Beatrice Casadei, et al. · European Journal of Cancer · 2
PDF
Palliative care is related to less aggressive end-of-life treatment in haematology-oncology: a retrospective cohort study
2025 · Davide Facchinelli, Corinna Greco, et al. · BMJ Supportive & Palliative Care · 2
Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia
2024 · Alessandro Cellini, Alessandro Salvalaggio, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
Severe haemorrhagic diathesis due to acquired hypofibrinogenemia in a patient with early T-cell precursor acute lymphoblastic leukaemia/lymphoma: a case report
2024 · Luca Spiezia, Marcello Riva, et al. · Frontiers in Cardiovascular Medicine · 2
PDF
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
2023 · Francesco Autore, Stefania Bramanti, et al. · Haematologica · 2
PDF
CAR-T: un’opzione efficace nel paziente refrattario primario
2026 · Maria Chiara Tisi, Michele Wieczorek, et al. · Recenti Progressi in Medicina · 1
PDF
P1674: Pap Score (palliative Prognostic Score) Estimates Short-term Survival in a Cohort of Hematological Patients
2023 · Davide Facchinelli, Pietro Manno, et al. · HemaSphere · 1
Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center Experience
2021 · Marcello Riva, Tamara Berno, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial
2026 · Riccardo Moia, Mohammad Almasri, et al. · Blood Advances
Works count: 34
Citation count: 182
H-index: 7
I10-index: 6
Year
Topic
Type